Concord is one of India’s leading manufacturers of fermentation based niche biopharma APIs focussed on immunosuppressant, oncology, antifungal and antibacterial therapies
The Company has a product portfolio of 18 existing products across 8 therapeutic areas
Concord operates across both regulated (US, EU and Japan) and semi-regulated markets (LATAM, Africa, CIS and MENA)